Svetlana Mukhina PhD, MSc

Dr. Svetlana Mukhina is leading global CDx regulatory activities for several Precision Medicine development programs at Merck KGaA. In this role, she closely works with companion diagnostic development manufacturers and internal stakeholders in the EU, US, and Asian countries to develop regulatory strategies enabling drug/CDx co-development and registration. Svetlana holds a Ph.D. in Biology and an MSc in Regulatory Affairs, with a focus on the regulation of in vitro companion diagnostic devices. Overall, she has over 10 years’ experience in Pharma and Biotech industry.